Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches

NCT07432347 is registered in ClinicalTrials.gov with Niguarda Hospital as lead sponsor.

NCT NCT07432347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07432347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches
Lead sponsor
Niguarda Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2026
Completion date
January 31, 2031
Enrollment
270 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocarcinoma